The genes targeted by AMK in the context of gastric cancer include apoptosis regulator Bcl-2 (BCL2), catenin beta 1 (CTNNB1), B-cell stimulatory factor 2 (IL6), mutated in multiple advanced cancers 1 (PTEN), proto-oncogene (SRC), and tumor necrosis factor ligand member 2 (TNF). This evidence concerns the gene IL6 and gastric cancer.